Finance

Lists
Why is VRCA down 2.32%?
Dive Deeper
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
$4.21
-2.32%
(-0.100) 1D
$4.29
+1.90% (+0.080)
Pre-market
Closed: Oct 6, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
$4.36
High
$4.41
Low
$4.17
Mkt. cap
73.50M
Avg. vol.
77.00K
Volume
2.00
52-wk high
$9.82
52-wk low
$3.28
EPS
-$1.67
Beta
1.60
Shares outstanding
17.18M
No. of employees
76
Open
$4.36
High
$4.41
Low
$4.17
Mkt. cap
73.50M
Avg. vol.
77.00K
Volume
2.00
52-wk high
$9.82
52-wk low
$3.28
EPS
-$1.67
Beta
1.60
Shares outstanding
17.18M
No. of employees
76
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees76
Founded2013
HeadquartersWest Chester, Pennsylvania, United States
SectorPharmaceutical industry
Websiteverrica.com
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current $4.21
$20.00 (+375.06%)
Average
$13.67 (+224.70%)
Lowest
$9.00 (+113.78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
$9.00
+113.8%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$12.00
+185%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
$20.00
+375.1%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
$17.00
+303.8%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
14.34M
5.09M
5.02M
5.86M
Cost of goods sold
3.31M
3.92M
4.75M
6.91M
Cost of revenue
3.31M
3.92M
4.75M
6.91M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.40M
8.12M
9.99M
10.35M
Operating expense
9.40M
8.12M
9.99M
10.35M
Total operating expenses
12.72M
12.04M
14.74M
17.26M
Operating income
1.63M
-6.95M
-9.72M
-11.40M
Other non operating income
34.00K
1.76M
-8.00K
-3.00K
EBT including unusual items
-274.00K
-8.07M
-9.68M
-13.15M
EBT excluding unusual items
-274.00K
-6.30M
-9.68M
-11.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-274.00K
-8.07M
-9.68M
-13.15M
Net profit margin
-1.91%
-158.56%
-192.75%
-224.38%
Earnings per share
0.13
-0.51
-0.45
-0.48
Interest and investment income
159.00K
205.00K
201.00K
111.00K
Interest expense
-2.09M
-1.31M
-160.00K
-164.00K
Net interest expenses
-1.94M
-1.11M
41.00K
-53.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.74M
-6.83M
-9.60M
-11.27M
Gain or loss from assets sale
68.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps